The PEDro prize is awarded to the person who presents the best report of a randomised controlled trial at the World Physiotherapy Congress. The award recognises the achievements of researchers who conduct high quality, clinically important randomised controlled trials. To be eligible, the presentation must have been a primary report for a completed randomised controlled trial that evaluates the effects of a physiotherapy intervention.
Judging was carried out by a panel of international trialists. Scoring was based on quality (risk of bias, size, design and analysis of the trial) as well as significance (importance of the findings for clinical practice).
The #WorldPhysio2021 winner was Rachael Cowan for her presentation titled “Hormone therapy and exercise as interventions for post-menopausal women with greater trochanteric pain syndrome: a randomised controlled trial”. The trial concluded that menopausal hormone therapy combined with any exercise and education resulted in reduced pain and increased function for post-menopausal women with greater trochanteric pain syndrome when body mass index was <25. Exercise with education surrounding avoidance of gluteal tendon compression is beneficial for this population, regardless of body mass index.
The results of the trial will be published soon, and we are looking forward to indexing this article in PEDro. Links to the trial protocol and trial registration are provided below.
Pictured is Rachael Cowan presenting at #WorldPhysio2021.
